Condensed Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash flows from Operating Activities
Net income (loss)	$ (1,313,773)	$ 506,312
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	16,597	19,851
Common stock issued for salaries and services	422,411	52,604
Fair value of options granted	37,046	240,567
Inducement expense		4,457
Change in fair value of derivative liabilities	(36,468)	(1,668,336)
Amortization of debt discount	81,533
Gain on conversion of debt	(6,907)
Imputed interest on related party notes	17,100
Changes in operating assets and liabilities:
Prepaid expense and other current assets	129,046	(48,426)
Accounts payable and accrued expenses	253,710	218,433
Accrued interest - related parties	90,000	90,000
Net cash used in operating activities	(309,705)	(584,538)
Cash flows from Investing Activities
Investment in patents	(2,808)	(11,733)
Net cash used in investing activities	(2,808)	(11,733)
Cash flows from Financing Activities
Proceeds from exercise of warrants and options		138,200
Issuance of common stock for cash	88,000	304,415
Payment of dividends on preferred stock		1,228
Proceeds from convertible debt, net	(103,000)
Proceeds from notes payable	70,000
Payments on convertible debt	(53,000)
Proceeds from notes payable related party	85,000
Issuances of convertible preferred stock, net	18,000	135,000
Net cash provided by financing activities	311,000	576,387
Net decrease in cash	(1,513)	(19,884)
Cash and cash equivalents at beginning of period	4,332	24,216
Cash and cash equivalents at end of period	2,819	4,332
Supplemental Cash Flow Information
Cash paid for interest	6,679	3,893
Non-Cash Transactions
Common stock issued for convertible debt	14,750
Discount on convertible debt	103,000
Acquisition of warrants for note payable		200,000
Declared and unpaid dividends on preferred stock		$ 2,972